Humana (NYSE:HUM) Now Covered by Piper Sandler

Piper Sandler started coverage on shares of Humana (NYSE:HUM) in a research report report published on Wednesday morning, MarketBeat reports. The brokerage issued an overweight rating and a $392.00 target price on the insurance provider’s stock.

A number of other equities analysts have also recently weighed in on the stock. Argus cut shares of Humana from a buy rating to a hold rating in a research report on Wednesday, March 13th. Raymond James started coverage on shares of Humana in a research report on Friday, March 22nd. They set a market perform rating on the stock. Barclays reduced their price target on shares of Humana from $356.00 to $310.00 and set an equal weight rating on the stock in a research report on Tuesday, April 2nd. UBS Group reduced their price target on shares of Humana from $334.00 to $326.00 and set a neutral rating on the stock in a research report on Thursday, April 25th. Finally, Morgan Stanley started coverage on shares of Humana in a research report on Monday, June 24th. They set an equal weight rating and a $374.00 price target on the stock. Fourteen investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat.com, Humana currently has an average rating of Hold and a consensus target price of $409.55.

Humana Price Performance

HUM opened at $373.65 on Wednesday. The company has a fifty day moving average price of $343.78 and a two-hundred day moving average price of $351.23. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67. Humana has a 52 week low of $298.61 and a 52 week high of $530.54. The firm has a market capitalization of $45.02 billion, a PE ratio of 23.27, a P/E/G ratio of 2.10 and a beta of 0.53.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. Humana had a net margin of 1.82% and a return on equity of 17.76%. The firm had revenue of $29.61 billion during the quarter, compared to analyst estimates of $28.52 billion. During the same quarter in the previous year, the business earned $9.38 EPS. The business’s quarterly revenue was up 10.7% compared to the same quarter last year. As a group, analysts anticipate that Humana will post 16.27 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a $0.885 dividend. The ex-dividend date is Friday, June 28th. This represents a $3.54 annualized dividend and a yield of 0.95%. Humana’s payout ratio is currently 22.04%.

Institutional Investors Weigh In On Humana

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Clear Rock Advisors LLC increased its stake in Humana by 4.0% in the 1st quarter. Clear Rock Advisors LLC now owns 5,131 shares of the insurance provider’s stock valued at $1,779,000 after buying an additional 199 shares during the last quarter. Cetera Advisors LLC increased its stake in shares of Humana by 472.1% during the 1st quarter. Cetera Advisors LLC now owns 10,098 shares of the insurance provider’s stock worth $3,501,000 after purchasing an additional 8,333 shares during the last quarter. Cetera Investment Advisers increased its stake in shares of Humana by 249.0% during the 1st quarter. Cetera Investment Advisers now owns 20,945 shares of the insurance provider’s stock worth $7,262,000 after purchasing an additional 14,944 shares during the last quarter. Atria Investments Inc increased its stake in shares of Humana by 14.5% during the 1st quarter. Atria Investments Inc now owns 5,329 shares of the insurance provider’s stock worth $1,848,000 after purchasing an additional 673 shares during the last quarter. Finally, Swedbank AB acquired a new position in shares of Humana during the 1st quarter worth about $37,174,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.